loading
Precedente Chiudi:
$1.142
Aprire:
$1.17
Volume 24 ore:
5,611
Relative Volume:
0.07
Capitalizzazione di mercato:
$27.66M
Reddito:
-
Utile/perdita netta:
$-22.29M
Rapporto P/E:
-0.9909
EPS:
-1.18
Flusso di cassa netto:
$-17.12M
1 W Prestazione:
-1.74%
1M Prestazione:
-7.20%
6M Prestazione:
-0.91%
1 anno Prestazione:
-15.88%
Intervallo 1D:
Value
$1.1693
$1.1777
Intervallo di 1 settimana:
Value
$1.13
$1.32
Portata 52W:
Value
$0.8101
$1.76

Enlivex Therapeutics Ltd Stock (ENLV) Company Profile

Name
Nome
Enlivex Therapeutics Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
36
Name
Cinguettio
@EnlivexT
Name
Prossima data di guadagno
2024-09-09
Name
Ultimi documenti SEC
Name
ENLV's Discussions on Twitter

Confronta ENLV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ENLV
Enlivex Therapeutics Ltd
1.1693 27.90M 0 -22.29M -17.12M -1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.53 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.35 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.50 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
593.70 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.62 31.91B 3.81B -644.79M -669.77M -6.24

Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-03-02 Reiterato H.C. Wainwright Buy

Enlivex Therapeutics Ltd Borsa (ENLV) Ultime notizie

pulisher
08:36 AM

Enlivex Therapeutics’ (ENLV) Buy Rating Reiterated at D. Boral Capital - Defense World

08:36 AM
pulisher
08:31 AM

Enlivex Therapeutics Ltd. Stock Analysis and ForecastFree Stock Market Query - PrintWeekIndia

08:31 AM
pulisher
12:08 PM

What drives Enlivex Therapeutics Ltd. stock priceFree Capital Growth Strategies - PrintWeekIndia

12:08 PM
pulisher
Jul 23, 2025

Is Enlivex Therapeutics Ltd. a good long term investmentExceptional profit velocity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Enlivex Therapeutics Ltd. stockExceptional market positioning - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Enlivex Therapeutics (ENLV) Receives Continued 'Buy' Rating from Analyst | ENLV Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 16, 2025

why enlivex therapeutics ltd. stock attracts strong analyst attentionLow Risk Entry Points - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why Enlivex Therapeutics Ltd. stock attracts strong analyst attentionReal Trader Insights - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

How Enlivex Therapeutics Ltd. stock performs during market volatilityPrecision Entry Strategy - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Enlivex Therapeutics Ltd. stock price move sharplyReturn Maximized Portfolio Strategy - Newser

Jul 15, 2025
pulisher
Jun 17, 2025

Sepsis Market Growth to Accelerate in Forecast Period - openPR.com

Jun 17, 2025
pulisher
Jun 13, 2025

Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Jeffersonian

Jun 13, 2025
pulisher
Jun 13, 2025

Trust Consulting Services CEO James Radford Named One of CIO Bulletin's "Best Entrepreneurs to Watch 2025" - Marco Eagle

Jun 13, 2025
pulisher
Jun 13, 2025

Unusual Machines Announces Termination of Definitive Agreement to Acquire Aloft - The Holland Sentinel

Jun 13, 2025
pulisher
Jun 13, 2025

Safe 'N' Sound Environmental Services Ltd. Recognized with 2025 Consumer Choice Award for Asbestos Removal in Halton Region - Sarasota Herald-Tribune

Jun 13, 2025
pulisher
Jun 11, 2025

Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025 - IndyStar

Jun 11, 2025
pulisher
Jun 10, 2025

Enlivex Therapeutics (ENLV) to Present Promising Allocetra Data at EULAR Congress | ENLV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enlivex Therapeutics to Present Clinical Data of Allocetra in Os - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enlivex Therapeutics Ltd. to Present Allocetra™ Data at EULAR 2025 Congress in Barcelona - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Breakthrough Cell Therapy Shows Promise in Knee Osteoarthritis: Enlivex Phase I/II Trial Data at EULAR 2025 - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Interactive Strength Inc. (Nasdaq: TRNR) Updates FAQ's about Increasing 2025 Pro Forma Revenue Guidance to More Than $75M and Other Questions - Reno Gazette Journal

Jun 10, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Acquires New Holdings in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Friday - Defense World

Jun 06, 2025
pulisher
Jun 02, 2025

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform - El Paso Times

Jun 02, 2025
pulisher
May 30, 2025

Enlivex Reports Q1 2025 Financial Results with Reduced Loss - TipRanks

May 30, 2025
pulisher
May 29, 2025

D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering - Lohud

May 29, 2025
pulisher
May 29, 2025

Enlivex Therapeutics (NASDAQ:ENLV) Shares Down 4% – Time to Sell? - Defense World

May 29, 2025

Enlivex Therapeutics Ltd Azioni (ENLV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Capitalizzazione:     |  Volume (24 ore):